Nanophase Technologies Corporation (NANX)
Chart Events
Performance Outlook
| Previous Close | 3.3300 |
| Open | 3.3100 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 3.0000 - 3.4400 |
| 52 Week Range | 1.4100 - 4.4500 |
| Volume | |
| Avg. Volume | 25,065 |
| Market Cap | 158.358M |
| Beta (5Y Monthly) | 1.27 |
| PE Ratio (TTM) | 47.10 |
| EPS (TTM) | 0.0690 |
| Earnings Date | Mar 09, 2022 - Mar 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.50 |
- GlobeNewswire
Nanophase Reports Record Revenue for First Quarter as it Sets Stage for Strong Year
— Delivered a record $8.2 million in Q1 revenue — In Beauty Science markets, Solésence revenue is up 29% YOY while Active Pharmaceutical Ingredients (API) sales are up 70% — Added key team members to support growth ROMEOVILLE, Ill., May 11, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors
- GlobeNewswire
Nanophase Technologies Announces First Quarter 2022 Financial Release and Conference Call Details
Romeoville, IL., May 04, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the First Quarter 2022 after market close on Wednesday, May 11, 2022, with an investor conference call to fol
- GlobeNewswire
Set Up For Strong Growth, Nanophase Reports Second Consecutive Year of Record Financial Results for 2021 as Solésence Continues to Lead and Personal Care Ingredients Category Thrives
— Another record year with 70% YOY growth — Delivered $29 Million in full year revenue — In Beauty Science markets, Solésence revenue is up 170% YOY while Active Pharmaceutical Ingredients (API) sales are up 40% — Acquired new facility space to support strategic growth and improve operational effectiveness — Closed on January 2022 financing to double borrowing capacity ROMEOVILLE, Ill., March 31, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-base
